NEW ORLEANS -- In a finding that ran counter to prior research, intravenous iron supplementation failed to boost the benefits of erythropoiesis-stimulating agents (ESAs) in cancer patients with chemotherapy-induced anemia, according to data from the largest study of its kind...Read More